CONTEXT: Obesity in adolescents is increasingly prevalent and its impact on cardiovascular risk important to determine. Hormonal predictors of cardiovascular risk markers in obese adolescents are not known. OBJECTIVE: Our objective was to examine whether relative GH deficiency and cortisol excess are determinants of increased cardiovascular risk markers in obese teenage girls. DESIGN AND SETTING: A cross-sectional study was conducted at a clinical research center. STUDY PARTICIPANTS: Thirty girls (15 obese girls and 15 normal-weight controls) 12-18 years old matched for maturity and race. MAIN OUTCOME MEASURES: Inflammatory markers of cardiovascular risk including high-sensitivity C-reactive protein (hsCRP), TNF-alpha receptors 1 and 2, E-selectin, soluble intercellular adhesion molecule-1, and IL-6 were analyzed. Leptin, adiponectin, and 24-h urine free cortisol (UFC) were also measured. A GHRH-arginine stimulation test was performed. RESULTS: The hsCRP levels were higher in obese girls than controls (4.63 +/- 4.81 vs. 0.67 +/- 0.72 mg/liter; P = 0.002 after log conversion), as were other markers of cardiovascular risk. Eight of the 15 obese girls but no normal-weight girl had hsCRP higher than 3 mg/liter (P = 0.002). Body mass index sd score was higher than 4.0 in 87.5% of girls with hsCRP higher than 3 mg/liter and no girls with hsCRP less than 3 mg/liter. Girls with hsCRP higher than 3 mg/liter had higher UFC and lower peak GH compared with those with hsCRP less than 3 mg/liter. Peak GH was an important negative predictor of most markers of increased cardiovascular risk. In addition to peak GH, UFC and adiponectin independently predicted hsCRP. CONCLUSION: Relative GH deficiency and cortisol excess are significant contributors to increased levels of markers of cardiovascular risk in obese adolescent girls.
CONTEXT: Obesity in adolescents is increasingly prevalent and its impact on cardiovascular risk important to determine. Hormonal predictors of cardiovascular risk markers in obese adolescents are not known. OBJECTIVE: Our objective was to examine whether relative GH deficiency and cortisol excess are determinants of increased cardiovascular risk markers in obese teenage girls. DESIGN AND SETTING: A cross-sectional study was conducted at a clinical research center. STUDY PARTICIPANTS: Thirty girls (15 obese girls and 15 normal-weight controls) 12-18 years old matched for maturity and race. MAIN OUTCOME MEASURES: Inflammatory markers of cardiovascular risk including high-sensitivity C-reactive protein (hsCRP), TNF-alpha receptors 1 and 2, E-selectin, soluble intercellular adhesion molecule-1, and IL-6 were analyzed. Leptin, adiponectin, and 24-h urine free cortisol (UFC) were also measured. A GHRH-arginine stimulation test was performed. RESULTS: The hsCRP levels were higher in obesegirls than controls (4.63 +/- 4.81 vs. 0.67 +/- 0.72 mg/liter; P = 0.002 after log conversion), as were other markers of cardiovascular risk. Eight of the 15 obese girls but no normal-weight girl had hsCRP higher than 3 mg/liter (P = 0.002). Body mass index sd score was higher than 4.0 in 87.5% of girls with hsCRP higher than 3 mg/liter and no girls with hsCRP less than 3 mg/liter. Girls with hsCRP higher than 3 mg/liter had higher UFC and lower peak GH compared with those with hsCRP less than 3 mg/liter. Peak GH was an important negative predictor of most markers of increased cardiovascular risk. In addition to peak GH, UFC and adiponectin independently predicted hsCRP. CONCLUSION: Relative GH deficiency and cortisol excess are significant contributors to increased levels of markers of cardiovascular risk in obese adolescent girls.
Authors: Paul M Ridker; Nancy J Brown; Douglas E Vaughan; David G Harrison; Jawahar L Mehta Journal: Circulation Date: 2004-06-29 Impact factor: 29.690
Authors: Beverly M K Biller; Mary H Samuels; Anthony Zagar; David M Cook; Baha M Arafah; Vivien Bonert; Stavros Stavrou; David L Kleinberg; John J Chipman; Mark L Hartman Journal: J Clin Endocrinol Metab Date: 2002-05 Impact factor: 5.958
Authors: Tobias Pischon; Cynthia J Girman; Gokhan S Hotamisligil; Nader Rifai; Frank B Hu; Eric B Rimm Journal: JAMA Date: 2004-04-14 Impact factor: 56.272
Authors: Ram Weiss; James Dziura; Tania S Burgert; William V Tamborlane; Sara E Taksali; Catherine W Yeckel; Karin Allen; Melinda Lopes; Mary Savoye; John Morrison; Robert S Sherwin; Sonia Caprio Journal: N Engl J Med Date: 2004-06-03 Impact factor: 91.245
Authors: Arthur Weltman; Jean Pierre Despres; Jody L Clasey; Judy Y Weltman; Laurie Wideman; Jill Kanaley; James Patrie; Jean Bergeron; Michael O Thorner; Claude Bouchard; Mark L Hartman Journal: Metabolism Date: 2003-01 Impact factor: 8.694
Authors: Carla R P Oliveira; Roberto Salvatori; Rafael A Meneguz-Moreno; Manuel H Aguiar-Oliveira; Rossana M C Pereira; Eugênia H A Valença; Vanessa P Araujo; Natália T Farias; Débora C R Silveira; Jose G H Vieira; Jose A S Barreto-Filho Journal: J Clin Endocrinol Metab Date: 2009-12-16 Impact factor: 5.958
Authors: Peter Hosick; Robert McMurray; A C Hackney; Claudio Battaglini; Terry Combs; Joanne Harrell Journal: Pediatr Exerc Sci Date: 2013-03-15 Impact factor: 2.333
Authors: Gabriela R S Veiga; Haroldo S Ferreira; Ana L Sawaya; Jairo Calado; Telma M M T Florêncio Journal: Int J Environ Res Public Health Date: 2010-11-30 Impact factor: 3.390